Doxycycline hyclate is a salt form used in U.S. prescription doxycycline products. It appears on capsule and tablet labeling, including some delayed-release products. For a pharmacy decision, “hyclate” identifies part of the medicine’s product specification rather than a universal dosing schedule or a promise that all hyclate items are identical.
Product descriptions can differ by dosage form, strength and release technology. A conventional hyclate capsule and a delayed-release hyclate tablet share a salt designation yet may have different administration and substitution rules. The patient’s actual prescription determines which presentation is needed.
This page focuses on hyclate product recognition and pharmacy checks. For the other common salt, see monohydrate products; for a direct comparison, see hyclate versus monohydrate.
Doxycycline hyclate is a form of the doxycycline active ingredient used in some labeled oral medicines. U.S. labels commonly express the strength as an amount equivalent to doxycycline rather than asking patients to calculate the mass of the salt themselves.
A prescription for a specific hyclate product should be matched to the corresponding strength, form and instructions. The salt name by itself is not evidence that a product is immediate-release or delayed-release.
DailyMed includes labeling for hyclate capsules with common strengths and separate hyclate tablets. Pharmacy product entries may specify different imprints, manufacturers and package quantities even within a single strength.
Use doxycycline capsule products or tablet product comparisons for dosage-form decisions beyond the specific hyclate identity.
Some hyclate tablets use specially coated pellets and carry labeling warning not to substitute them on a milligram-for-milligram basis with other oral doxycyclines. This is a formulation issue, not simply a difference in the manufacturer’s preferred packaging.
A patient who previously used an immediate-release hyclate capsule should not independently replace it with a delayed-release hyclate tablet. See delayed-release product selection for the label-specific rules.
These fields distinguish different hyclate entries on the pharmacy shelf.
| Hyclate product characteristic | Examples to distinguish | Pharmacy action |
|---|---|---|
| Salt | Doxycycline hyclate | Confirm as prescribed |
| Form | Capsule or tablet | Match dosage form |
| Release | Conventional or delayed-release tablet | Review special substitution limits |
| Strength | 100 mg and other labeled strengths | Match full product and directions |
| Manufacturer | Different labeled generic products | Check product and equivalence record |
The common 100 mg search phrase describes a nominal doxycycline strength, not a complete drug product. Different strengths or release forms may be listed separately, and package count is another dimension.
The doxycycline 100 mg guide shows why a strength search crosses both hyclate and monohydrate families; this hyclate page is concerned with the salt-specific range.
Doxycycline products can cause esophageal irritation, and official labels counsel sufficient fluid. Some forms have specific food, tablet-handling or delayed-release instructions. Patients should not apply one page’s handling advice across all hyclate products without confirming the precise label.
Medication interactions involving antacids containing minerals and iron-containing products also deserve review. Ask the pharmacist for the instructions that apply to the actual dispensed hyclate formulation.
A pharmacist may propose an FDA-approved generic consistent with the prescription and relevant equivalence rules. However, the word “hyclate” should not be used to bypass a release-form requirement or substitute a different dosage form without review.
The generic product guide explains where FDA equivalence records help and why an approval record does not guarantee stock.
Some branded doxycycline products use doxycycline hyclate and specialized release designs. A brand connection does not establish that the original product is currently available in every pharmacy or that ordinary hyclate capsules can replace it.
For modified-polymer-coat branded formulations, see Doryx MPC product distinctions. Always verify current labeling and the pharmacy’s proposed product.
A conventional hyclate capsule may have a different quote from a delayed-release hyclate tablet. Comparing those prices without checking pharmaceutical appropriateness can produce a false affordability conclusion.
Request a total for the clinically appropriate form and quantity from a licensed pharmacy. No generic cost figure or brand availability is presumed here.
Hyclate is a salt form of doxycycline. The specific medicine is identified by its complete product formulation and strength.
Yes. U.S. DailyMed labeling includes doxycycline hyclate capsules.
No automatic substitution should be assumed; dosage form and release characteristics must be reviewed.
No. Delayed-release doxycycline hyclate tablet formulations also exist.
No. Release form, quantity, manufacturer and pharmacy can change the quote.
Labels may express the amount as doxycycline active moiety while identifying the salt separately.
Discuss an individual change with the clinician or pharmacist; do not assume an across-the-board difference or make the change yourself.